Nuffield Department of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Haemostasis and Blood Conservation Service, John Radcliffe Hospital, Oxford, Oxon, UK.
Br J Haematol. 2023 Mar;200(5):652-659. doi: 10.1111/bjh.18523. Epub 2022 Oct 17.
The loss of 50% blood volume is one accepted definition of massive haemorrhage, which ordinarily would trigger the massive transfusion protocol, involving the administration of high ratios of fresh frozen plasma and platelets to allogeneic red cells. We investigated 53 patients who experienced >50% blood loss during open elective abdominal aortic aneurysm surgery to assess allogeneic blood component usage and coagulopathy. Specialist patient blood management practitioners used a tailored cell salvage technique including swab wash to maximise blood return. We assessed the proportion of patients who did not require allogeneic blood components and develop evidence of coagulopathy by thromboelastography (TEG) parameters. Blood loss was 50%-174% (mean [SD] 68% [27%]) of blood volume. The mean (SD) intraoperative decrease in haemoglobin concentration, assessed by arterial blood gas analysis, was 5 (13) g/l. No patient received allogeneic red cells intraoperatively. Four of the 53 (8%) patients received blood components in the first 24 h postoperatively at the anaesthetists' discretion. No patient had intraoperative TEG changes indicative of fibrinolysis or coagulopathy. The 30-day mortality was 2% (one of 53). Reduction of allogeneic transfusion is one aim of patient blood management techniques. We have demonstrated virtual avoidance of allogeneic blood product transfusion despite massive blood loss. These data show possible alternatives to the current massive transfusion protocols to the management of elective vascular surgical patients.
失血量达到 50%是公认的大出血定义,通常会触发大量输血方案,包括给予高比例的新鲜冷冻血浆和血小板与异体红细胞。我们调查了 53 名在开放性择期腹主动脉瘤手术中经历>50%失血的患者,以评估异体血液成分的使用和凝血功能障碍。专业的患者血液管理从业者使用定制的细胞回收技术,包括拭子清洗,以最大限度地回收血液。我们评估了不需要异体血液成分的患者比例,并通过血栓弹性图(TEG)参数评估凝血功能障碍的发生情况。失血量为 50%-174%(平均值[标准差]为 68%[27%])。通过动脉血气分析评估的术中血红蛋白浓度平均值(标准差)下降了 5(13)g/L。没有患者在术中接受异体红细胞。53 名患者中有 4 名(8%)在术后 24 小时内根据麻醉师的判断接受了血液成分。没有患者出现 TEG 变化提示纤溶或凝血功能障碍。30 天死亡率为 2%(53 例中有 1 例)。减少异体输血是患者血液管理技术的一个目标。尽管失血量大,但我们已经证明可以几乎避免异体血液产品的输血。这些数据显示了替代当前大量输血方案的可能性,用于管理择期血管手术患者。